Back to search results

ALTO-100 in Bipolar Disorder With Depression (BD-D)

Abroad (travel likely)RecruitingPHASE2

Conditions

Bipolar Disorder I or II With a Major Depressive Episode

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Site 6036, Chandler, Arizona, United States

  • Site 6000, Phoenix, Arizona, United States

  • Site 6087, Yuma, Arizona, United States

  • 6039, Fayetteville, Arkansas, United States

  • 6070, Little Rock, Arkansas, United States

  • Site 6081, Imperial, California, United States

  • 6069, Los Angeles, California, United States

  • Site 6016, Mather, California, United States

  • Site 6082, Oceanside, California, United States

  • Site 6102, Riverside, California, United States

  • Site 6112, Colorado Springs, Colorado, United States

  • Site 6067, Lauderhill, Florida, United States

  • Site 6068, Atlanta, Georgia, United States

  • Site 6064, Peachtree Corners, Georgia, United States

  • Site 6151, Baltimore, Maryland, United States

  • Site 6076, Bel Air, Maryland, United States

  • Site 6062, Gaithersburg, Maryland, United States

  • Site 6142, Lincoln, Nebraska, United States

  • Site 6144, Las Vegas, Nevada, United States

  • Site 6104, Las Vegas, Nevada, United States

  • Site 6066, Toms River, New Jersey, United States

  • Site 6014, Albuquerque, New Mexico, United States

  • Site 6078, Albuquerque, New Mexico, United States

  • 6065, North Canton, Ohio, United States

  • Site 6075, Westlake, Ohio, United States

  • Site 6072, Houston, Texas, United States

  • Site 6121, Draper, Utah, United States

Study leads

  • Adam Savitz, MD, PhD

    Study Director

    Alto Neuroscience

View source on ClinicalTrials.gov(opens in a new tab)